Anti-ribosomal P protein antibodies

Autoimmunity

Volumn 38, Issue 1, 2005, Pages 85-92

  Gerli, Roberto ^a,c   Caponi, Laura ^b  

^a UNIVERSITY OF PERUGIA   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c POLICLINICO MONTELUCE   (Italy)

Author keywords

Anti P proteins; Anti ribosomal antibodies; Connective tissue diseases; Systemic lupus erythematosus

Indexed keywords

AUTOANTIBODY; DNA ANTIBODY; GLYCINE CLEAVAGE SYSTEM; RIBOSOME PROTEIN; RIBOSOME PROTEIN P ANTIBODY; SM ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY SPECIFICITY; CONNECTIVE TISSUE DISEASE; CROSS REACTION; DISEASE ASSOCIATION; HUMAN; KIDNEY DISEASE; LIVER DISEASE; MENTAL DISEASE; MOLECULAR RECOGNITION; MOLECULAR WEIGHT; NEUROLOGIC DISEASE; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; REVIEW; RIBOSOME SUBUNIT; SEROLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS;

AUTOANTIBODIES; CONNECTIVE TISSUE DISEASES; HUMANS; IMMUNOASSAY; IMMUNOGLOBULIN ISOTYPES; LUPUS ERYTHEMATOSUS, SYSTEMIC; PHOSPHOPROTEINS; RIBOSOMAL PROTEINS;

EID: 17144414514     PISSN: 08916934     EISSN: None     Source Type: Journal    
DOI: 10.1080/08916930400022699     Document Type: Review

References (93)

1. Sturgill BC, Carpenter RR. Antibody to ribosomes in systemic lupus erythematosus. Arthritis Rheum 1965;8:213-218.
2. Tchorzewski M. The acidic ribosomal P proteins. Int J Biochem Cell Biol 2002;34:911-915.
3. Gordon J, Towbin H, Rosenthal M. Antibodies directed against ribosomal protein determinants in the sera of patients with connective tissue diseases. J Rheumatol 1982;9:247-252.
4. Towbin H, Ramjoue HP, Kuster H, Liverani D, Gordon J. Monoclonal antibodies against eucaryotic ribosomes. Use to characterize a ribosomal protein not previously identified and antigenically related to the acidic phosphoproteins P1/P2. J Biol Chem 1982;257:12709-12715.
5. Elkon KB, Parnassa AP, Foster CL. Lupus autoantibodies target ribosomal P proteins. J Exp Med 1985;162:459-471.
6. Tchorzewski M, Boldyreff B, Issinger O, Grankowski N. Analysis of the protein-protein interactions between the human acidic ribosomal P-proteins: evaluation by the two hybrid system. Int J Biochem Cell Biol 2000;32:737-746.
7. Wool IG, Chan YL, Gluck A. Structure and evolution of mammalian ribosomal proteins. Biochem Cell Biol 1995;73:933-947.
8. Tchorzewski M, Krokowski D, Rzeski W, Issinger OG, Grankowski N. The subcellular distribution of the human ribosomal stalk components: P1, P2 and P0 proteins. Int J Biochem Cell Biol 2003;35:203-211.
9. Zinker S, Warner JR. The ribosomal proteins of Saccharomyces cerevisiae. Phosphorylated and exchangeable proteins. J Biol Chem 1976;251:1799-1807.
10. Remacha M, Jimenez-Diaz A, Bermejo B, Rodriguez-Gabriel MA, Guarinos E, Ballesta JP. Ribosomal acidic phosphoproteins P1 and P2 are not required for cell viability but regulate the pattern of protein expression in Saccharomyces cerevisiae. Mol Cell Biol 1995;15:4754-4762.
11. Sanchez-Madrid F, Vidales FJ, Ballesta JP. Effect of phosphorylation on the affinity of acidic proteins from Saccharomyces cerevisiae for the ribosomes. Eur J Biochem 1981;114:609-613.
12. Lavergne JP, Conquet F, Reboud JP, Reboud AM. Role of acidic phosphoproteins in the partial reconstitution of the active 60 S ribosomal subunit. FEBS Lett 1987;216:83-88.
13. Vard C, Guillot D, Bargis P, Lavergne JP, Reboud JP. A specific role for the phosphorylation of mammalian acidic ribosomal protein P2. J Biol Chem 1997;272:20259-20262.
14. Bargis-Surgey P, Lavergne JP, Gonzalo P, Vard C, Filhol-Cochet O, Reboud JP. Interaction of elongation factor eEF-2 with ribosomal P proteins. Eur J Biochem 1999;262:606-611.
15. Ballesta JP, Rodriguez-Gabriel MA, Bou G, Briones E, Zambrano R, Remacha M. Phosphorylation of the yeast ribosomal stalk. Functional effects and enzymes involved in the process. FEMS Microbiol Rev 1999;23:537-550.
16. Saenz-Robles MT, Remacha M, Vilella MD, Zinker S, Ballesta JP. The acidic ribosomal proteins as regulators of the eukaryotic ribosomal activity. Biochem Biophys Acta 1990;1050:51-55.
17. Stacey DW, Skelly S, Watson T, Elkon K, Weissbach H, Brot N. The inhibition of protein synthesis by IgG containing anti-ribosome P autoantibodies from systemic lupus erythematosus patients. Arch Biochem Biophys 1988; 267:398-403.
18. Zampieri S, Mahler M, Bluthner M, Qiu Z, Malmegrim K, Ghirardello A, et al. Recombinant anti-P protein autoantibodies isolated from a human autoimmune library: Reactivity, specificity and epitope recognition. Cell Mol Life Sci 2003;60:588-598.
19. Koscec M, Koren E, Wolfson-Reichlin M, Fugate RD, Trieu E, Targoff IN, Reichlin M. Autoantibodies to ribosomal P proteins penetrate into live hepatocytes and cause cellular dysfunction in culture. J Immunol 1997;159:2033-2041.
20. Reichlin M. Cellular dysfunction induced by penetration of autoantibodies into living cells: cellular damage and dysfunction mediated by antibodies to dsDNA and ribosomal P proteins. J Autoimmun 1998;11:557-561.
21. Sun KH, Tang SJ, Lin ML, Wang YS, Sun GH, Liu WT. Monoclonal antibodies against human ribosomal P proteins penetrate into living cells and cause apoptosis of Jurkat T cells in culture. Rheumatology 2001;40:750-756.
22. Sun KH, Liu WT, Tang SJ, Tsai CY, Hsieh SC, Wu TH, Han SH, Yu CL. The expression of acidic ribosomal phosphoproteins on the surface membrane of different tissues in autoimmune and normal mice which are the target molecules for anti-double-stranded DNA antibodies. Immunology 1996;87:362-371.
23. Reichlin M. Presence of ribosomal P protein on the surface of human umbilical vein endothelial cells. J Rheumatol 1996;23:1123-1125.
24. Casciola-Rosen LA, Anhalt G, Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 1994;179:1317-1330.
25. Koren E, Reichlin MW, Koscec M, Fugate RD, Reichlin M. Autoantibodies to the ribosomal P proteins react with a plasma membrane-related target on human cells. J Clin Investig 1992;89:1236-1241.
26. Yoshio T, Masuyama J, Kano S. Antiribosomal P0 protein antibodies react with the surface of human umbilical vein endothelial cells. J Rheumatol 1996;23:1311-1312.
27. Stafford HA, Chen AE, Anderson CJ, Paul AG, Wyatt EL, Lee LA, Neas BR. Anti-ribosomal and P-peptide-specific autoantibodies bind to T lymphocytes. Clin Exp Immunol 1997;109:12-19.
28. Bonfa E, Parnassa AP, Rhoads DD, Roufa DJ, Wool IG, Elkon KB. Antiribosomal S10 antibodies in humans and MRL/lpr mice with systemic lupus erythematosus. Arthritis Rheum 1989;32:1252-1261.
29. Hasegawa H, Uchiumi T, Sato T, Ofuchi Y, Murakami S, Honda S, Hirose S, Ito S, Nakano M, Arakawa M, Gejyo F. High frequency of antibody activity against ribosomal protein S10 in anti-Sm sera from patients with systemic lupus erythematosus. Lupus 1999;8:439-443.
30. Anderson CJ, Neas BR, Uchiumi T, Stafford HA. Autoantibodies to the 20-kDa ribosomal proteins: identification, characterization, and new aspects on prevalence in systemic lupus erythematosus. Clin Immunol 2001;98:249-257.
31. Hasegawa H, Uchiumi T, Sato T, Saito A, Nakano M, Gejyo F. Autoantibody against ribosomal protein L14 in patients with systemic lupus erythematosus. Clin Exp Rheumatol 2002;20:139-144.
32. Sato T, Uchiumi T, Kominami R, Arakawa M. Autoantibodies specific for the 20-KDal ribosomal large subunit protein L12. Biochem Biophys Res Commun 1990;172:496-502.
33. Neu E, von Mikecz AH, Hemmerich PH, Peter HH, Fricke M, Deicher H, Genth E, Krawinkel U. Autoantibodies against eukaryotic protein L7 in patients suffering from systemic lupus erythematosus and progressive systemic sclerosis: Frequency and correlation with clinical, serological and genetic parameters. The SLE Study Group. Clin Exp Immunol 1995;100:198-204.
34. Mesri EA, Levitus G, Hontebeyrie-Joskowicz M, Dighiero G, Van Regenmortel MH, Levin MJ. Major Trypanosoma cruzi antigenic determinant in Chagas' heart disease shares homology with the systemic lupus erythematosus ribosomal P protein epitope. J Clin Microbiol 1990; 28:1219-1224.
35. Kaplan D, Ferrari I, Bergami PL, Mahler E, Levitus G, Chiale P, Hoebeke J, Van Regenmortel MH, Levin MJ. Antibodies to ribosomal P proteins of Trypanosoma cruzi in Chagas disease possess functional autoreactivity with heart tissue and differ from anti-P autoantibodies in lupus. Proc Natl Acad Sci USA 1997;94:10301-10306.
36. Mayer C, Appenzeller U, Seelbach H, Achatz G, Oberkofler H, Breitenbach M, Blaser K, Crameri R. Humoral and cell-mediated autoimmune reactions to human acidic ribosomal P2 protein in individuals sensitized to Aspergillus fumigatus P2 protein. J Exp Med 1999;189:1507-1512.
37. Kurup VP, Banerjee B. Fungal allergens and peptide epitopes. Peptides 2000;21:589-599.
38. Yoshio T, Masuyama J, Ikeda M, Tamai K, Hachiya T, Emori T, Mimori A, Takeda A, Minota S, Kano S. Quantification of antiribosomal P0 protein antibodies by ELISA with recombinant P0 fusion protein and their association with central nervous system disease in systemic lupus erythematosus. J Rheumatol 1995;22:1681-1687.
39. Yoshio T, Masuyama JI, Minota S, Kaneko N, Iwamoto M, Okazaki H, Mimori A, Takeda A, Kano S. A close temporal relationship of liver disease to antiribosomal P0 protein antibodies and central nervous system disease in patients with systemic lupus erythematosus. J Rheumatol 1998;25:681-688.
40. Stafford HA, Anderson CJ, Blalock DB, Reichlin M. Development of the anti-ribosomal P autoantibody response. Clin Exp Rheumatol 1998;16:119-124.
41. Ersvaer E, Bertelsen LT, Espenes LC, Bredholt T, Boe SO, Iversen BM, et al. Characterization of ribosomal P autoantibodies in relation to cell destruction and autoimmune disease. Scand J Immunol 2004;60:189-198.
42. Bonfa E, Chu JL, Brot N, Elkon KB. Lupus anti-ribosomal P peptide antibodies show limited heterogeneity and are predominantly of the IgG1 and IgG2 subclasses. Clin Immunol Immunopathol 1987;45:129-138.
43. Bonfa E, Llovet R, Elkon K. Immunoblot analysis of IgG subclasses of multiple lupus autoantibodies. J Immunol 1988;140:2231-2236.
44. Elkon KB, Bonfa E, Llovet R, Eisenberg RA. Association between anti-Sm and anti-ribosomal P protein autoantibodies in human systemic lupus erythematosus and MRL/lpr mice. J Immunol 1989;143:1549-1554.
45. Schur PH, Moroz LA, Kunkel HG. Precipitating antibodies to ribosomes in the serum of patients with SLE. Immunochemistry 1967;4:447-454.
46. Homberg JC, Rizzetto M, Doniach D. Ribosomal antibodies detected by immunofluorescence in systemic lupus erythematosus and other collagenoses. Clin Exp Immunol 1974;17:617-628.
47. Koffler D, Faiferman I, Gerber M. Radioimmunoassay for antibodies to cytoplasmic ribosomes in human serum. Science 1977;198:741-743.
48. Cavanagh D. A solid-phase radioimmunoassay for the detection of antibodies to ribosomes. Anal Biochem 1977;79:217-225.
49. Mathy JP, Baum R, Toh BH. Autoantibody to ribosomes and systemic lupus erythematosus. Clin Exp Immunol 1980;41:73-80.
50. Elkon KB, Skelly S, Parnassa AP, Dahno W, Weissbach H, Brot N. Identification and chemical synthesis of a ribosomal P protein antigenic determinant in systemic lupus erythematosus. Proc Natl Acad Sci USA 1986;83:7419-7423.
51. Elkon K, Bonfa E, Llovet R, Danho W, Weissbach H, Brot N. Properties of the ribosomal P2 protein autoantigen are similar to those of foreign protein antigens. Proc Natl Acad Sci USA 1988;85:5186-5189.
52. Spezialetti R, Bluestein HG, Peter JB, Alexander EL. Neuropsychiatric disease in Sjogren's syndrome: anti-ribosomal and anti-neuronal antibodies. Am J Med 1993;95:153-160.
53. Caponi L, Pegoraro S, Di Bartolo V, Rovero P, Revoltella R, Bombardieri S. Autoantibodies directed against ribosomal P proteins: use of a multiple antigen peptide as the coating agent in ELISA. J Immunol Methods 1995;179:193-202.
54. Fabien N, Moreira A, Lavergne JP, Desbos A, Surgey P, Alves de Olivera C, Gonzalo P, Venot A, Bienvenu J, Perrier H, Reboud JP, Monier JC. Autoantibodies directed against the ribosomal P proteins are not only directed against a common epitope of the P0, P1 and P2 proteins. J Autoimmun 1999;13:103-110.
55. Yoshio T, Masuyama JI, Minota S, Iwamoto M, Mimori A, Takeda A, Okazaki H, Kano S. Correlation of serum IgG antibodies to recombinant P0 fusion protein with IgG antibodies to carboxyl-terminal 22 synthetic peptides and carboxyl-terminal 22 amino acid-deleted recombinant P0 fusion protein in patients with systemic lupus erythematosus. Arthritis Rheum 1997;40:1364-1365.
56. Caponi L, Giordano A, Bartoloni EB, Gerli R. Detection of anti-ribosome antibodies: A long story of lights and shadows. Clin Exp Rheumatol 2003;21:771-778.
57. Rayno K, Reichlin M. Evaluation of assays for the detection of autoantibodies to the ribosomal P proteins. Clin Immunol 2000;95:99-103.
58. Ghirardello A, Caponi L, Franceschini F, Zampieri S, Quinzanini M, Bendo R, Bombardieri S, Gambari PF, Doria A. Diagnostic tests for antiribosomal p protein antibodies: A comparative evaluation of immunoblotting and ELISA assays. J Autoimmun 2002;19:71-77.
59. Mahler M, Kessenbrock K, Raats J, Fritzler MJ. Technical and clinical evaluation of anti-ribosomal P protein immunoassays. J Clin Lab Anal 2004;18:215-223.
60. Nojima Y, Minota S, Yamada A, Takaku F. Identification of an acidic ribosomal protein reactive with anti-Sm autoantibody. J Immunol 1989;143:1915-1920.
61. Chindalore V, Neas B, Reichlin M. The association between anti-ribosomal P antibodies and active nephritis in systemic lupus erythematosus. Clin Immunol Immunopathol 1998;87:292-296.
62. Reichlin M, Wolfson-Reichlin M. Correlations of anti-dsDNA and anti-ribosomal P autoantibodies with lupus nephritis. Clin Immunol 2003;108:69-72.
63. Takeda I, Rayno K, Wolfson-Reichlin M, Reichlin M. Heterogeneity of anti-dsDNA antibodies in their cross-reaction with ribosomal P protein. J Autoimmun 1999;13:423-428.
64. Caponi L, Bombardieri S, Migliorini P. Anti-ribosomal antibodies bind the Sm proteins D and B/B′. Clin Exp Immunol 1998;112:139-143.
65. Sun KH, Liu WT, Tsai CY, Tang SJ, Han SH, Yu CL. Anti-dsDNA antibodies cross-react with ribosomal P proteins expressed on the surface of glomerular mesangial cells to exert a cytostatic effect. Immunology 1995;85:262-269.
66. Caponi L, Chimenti D, Pratesi F, Migliorini P. Anti-ribosomal antibodies from lupus patients bind DNA. Clin Exp Immunol 2002;130:541-547.
67. Schneebaum AB, Singleton JD, West SG, Blodgett JK, Allen LG, Cheronis JC, Kotzin BL. Association of psychiatric manifestations with antibodies to ribosomal P proteins in systemic lupus erythematosus. Am J Med 1991;90:54-62.
68. Gerli R, Caponi L, Tincani A, Scorza R, Sabbadini MG, Danieli MG, et al. Clinical and serological associations of ribosomal P autoantibodies in systemic lupus erythematosus: prospective evaluation in a large cohort of Italian patients. Rheumatology 2002;41:1357-1366.
69. Cuchacovich R, Espinoza LR. Clinical and scrological associations of ribosomal P autoantibodies in systemic lupus erythematosus: Prospective evaluation in a large cohort of Italian patients. Rheumatology 2003;42:1115-1116.
70. Gerli R, Caponi L. Clinical and serological associations of ribosomal P autoantibodies in systemic lupus erythematosus: Prospective evaluation in a large cohort of Italian patients: reply. Rheumatology 2003;42:1116-1117.
71. Fujimoto M, Sato S, Takehara K, Nojima Y, Soma Y, Kikuchi K, et al. Detection of antiribosomal P protein antibodies in patients with systemic sclerosis. Br J Rheumatol 1995;34:908-911.
72. Hamasaki K, Mimura T, Kanda H, Morino N, Yazaki Y, Nojima Y. Development of systemic lupus erythematosus in a rheumatoid arthritis patient with anti-ribosomal P protein antibody. Lupus 1997;6:734-736.
73. Sato T, Uchiumi T, Ozawa T, Kikuchi M, Nakano M, Arakawa M. Autoantibodies against ribosomal proteins found with high frequency in patients with systemic lupus erythematosus with active disease. J Rheumatol 1991;18:1681-1684.
74. Press J, Palayew K, Laxer RM, Elkon K, Eddy A, Rakoff D, et al. Anti ribosomal P antibodies in pediatric patients with systemic lupus erythematosus and psychosis. Arthritis Rheum 1996;39:671-676.
75. Reichlin M, Broyles TF, Hubscher O, James J, Lehman TA, Palermo R, et al. Prevalence of autoantibodies to ribosomal P proteines in juvenile-onset systemic lupus erythematosus compared with the adult disease. Arthritis Rheum 1999;42:69-75.
76. Tzioufas AG, Tzortzakis NG, Panou-Pomonis E, Boki KA, Sakarellos-Daitsiotis M, Sakarellos C, et al. The clinical relevance of antibodies to ribosomal-P common epitope in two targeted systemic lupus erythematosus populations: A large cohort of consecutive patients and patients with active central nervous system disease. Ann Rheum Dis 2000;59:99-104.
77. Nojima Y, Minota S, Yamada A, Takaku F, Aotsuka S, Yokohari R. Correlation of antibodies to ribosomal P protein with psychosis in patients with systemic lupus erythematosus. Ann Rheum Dis 1992;51:1053-1055.
78. Teh LS, Hay EM, Amos N, Black D, Huddy A, Creed F, et al. Anti-P antibodies are associated with psychiatric and focal cerebral disorders in patients with systemic lupus erythematosus. Br J Rheumatol 1993;32:287-290.
79. Teh LS, Doherty DG, Williams BD. HLA-DRB genes and antiribosomal P antibodies in systemic lupus erythematosus. Br J Rheumatol 1994;33:1125-1126.
80. Arnett FC, Reveille GD, Moutsopoulos HM, Georgescu L, Elkon KB. Ribosomal P autoantibodies in systemic lupus erythematosus. Arthritis Rheum 1996;39:1833-1839.
81. Bonfa E, Golombek SJ, Kaufman LD, Skelly S, Weissbach H, Brot N, Elkon KB. Association between lupus psychosis and anti-ribosomal P protein antibodies. N Engl J Med 1987;317:265-271.
82. Van Dam A, Nossent H, de Jong J, Meilof J, ter Borg EJ, Swaak T, et al. Diagnostic value of antibodies against ribosomal phosphoproteins. A cross sectional and longitudinal study. J Rheumatol 1991;18:1026-1034.
83. Hanly JG, Walsh NM, Fisk JD, Eastwood B, Hong C, Sherwood G, et al. Cognitive impairment and autoantibodies in systemic lupus erythematosus. Br J Rheumatol 1993;32:291-296.
84. Isshi K, Irohata S. Association of anti-ribosomal P protein antibodies with neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 1996;39:1483-1490.
85. Massardo L, Burgos P, Martinez ME, Perez R, Calvo M, Barros J, et al. Antiribosomal P protein antibodies in chilean SLE patients: No associations with renal disease. Lupus 2002; 11:379-383.
86. Yalaoui S, Gorgi Y, Hajri R, Goucha R, Chaabouni L, Kooli C, et al. Autoantibodies to ribosomal P proteins in systemic lupus erythematosus. Joint Bone Spine 2002;69:173-176.
87. Reichlin M. Ribosomal P antibodies and CNS lupus. Lupus 2003;12:916-918.
88. Hoffman IEA, Peene I, Meheus L, Huizinga TWJ, Cebecauer L, Isenberg D, et al. Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosus. Ann Rheum Dis 2004;63:1155-1158.
89. Hulsey M, Goldstein R, Scully L, Surbeck W, Reichlin M. Anti-ribosomal P antibodies in systemic lupus erythematosus: a case-control study correlating hepatic and renal disease. Clin Immunol Immunopathol 1995; 74:252-256.
90. Martin AL, Reichlin M. Fluctuations of antibody to ribosomal P proteins correlate with appearance and remission of nephritis in SLE. Lupus 1996;5:22-29.
91. Koren E, Schnitz W, Reichlin M. Concomitant development of chronic active hepatitis and antibodies to ribosomal P proteins in a patient with systemic lupus erythematosus. Arthritis Rheum 1993;36:1325-1328.
92. Arnett FC, Reichlin M. Lupus hepatitis: an under-recognized disease feature associated with autoantibodies to ribosomal P. Am J Med 1995;99:465-472.
93. Koren E, Koscec M, Reichlin M, Fugate R, Reichlin M. Possible role of autoantibodies to ribosomal P proteins in development of liver disease in patients with systemic lupus erythematosus. Arthritis Rheum 1993;S36:72.